NCT06895967 - A Study of TAK-881 and HyQvia in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

July 24, 2025

Study Completion Date

July 24, 2025

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL

TAK-881

Participants will receive SC infusion of TAK-881.

BIOLOGICAL

HyQvia

Participants will receive SC infusion of HyQvia.

DEVICE

SC Investigational Needle Sets

The single-use only SC needle set will be used to administer TAK-881 to the target depth below the skin surface. One needle set (single or bifurcated) will be used per infusion.

DEVICE

SC Investigational Needle Sets

The single-use only SC needle set will be used to administer HyQvia to the target depth below the skin surface. One needle set (single or bifurcated) will be used per infusion.

Trial Locations (1)

85283

Celerion, Tempe